A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors

Clinical trial NCT04029688 · TERMINATED

Trial details

NCT number: NCT04029688
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Neuroblastoma Solid Tumors

Start date: 2020-01-27
Primary completion: 2024-05-06
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.